HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Ria T Caringal, Speaker at Immunology Conferences
University of Kansas, United States
Title : A combined LC-MS and immunoassay approach to characterize preservative-induced destabilization of human papillomavirus virus-like particles adsorbed to an aluminum-salt adjuvant

Abstract:

During the multi-dose formulation development of recombinant vaccine candidates, protein antigens can be destabilized by antimicrobial preservatives (APs). The degradation mechanisms are often poorly understood since available analytical tools are limited due to low protein concentrations and the presence of adjuvants. In this work, we evaluate different analytical approaches to monitor the structural integrity of HPV16 VLPs adsorbed to Alhydrogel™ (AH) in the presence and absence of APs (i.e., destabilizing m-cresol, MC, or non-destabilizing chlorobutanol, CB) under accelerated conditions (pH 7.4, 50 °C). First, in vitro potency losses displayed only modest correlations with the results from two commonly used methods of protein analysis (SDS-PAGE, DSC). Next, results from two alternative analytical approaches provided a better understanding of physicochemical events occurring under these same conditions: (1) competitive ELISA immunoassays with a panel of mAbs against conformational and linear epitopes on HPV16 VLPs and (2) LC-MS peptide mapping to evaluate the accessibility/redox state of the 12 cysteine residues within each L1 protein comprising the HPV16 VLP (i.e., with 360 L1 proteins per VLP, there are 4320 Cys residues per VLP). These methods expand the limited analytical toolset currently available to characterize AH-adsorbed antigens and provide additional insights into the molecular mechanism(s) of AP-induced destabilization of vaccine antigens.

Biography:

Ria T. Caringal earned her BS in Molecular Biology and Biotechnology at University of the Philippines – Diliman in 2011. She spent the next few years working as an associate scientist in vaccine formulation and development for both private industry (MedImmune) and government labs (NIH/NIAID/Vaccine Research Center). In 2020, she started her PhD studies at the Department of Pharmaceutical Chemistry at University of Kansas, with a focus on vaccines under Drs. David Volkin and Sangeeta Joshi at the Vaccine Analytics and Formulation Center (VAFC).

Watsapp